Witnesses testified about the shortage of flu vaccine in the U.S. The heads of federal medical agencies explained the loss of 42 million doses of the vaccine from a British pharmaceuticals company. 

Drug manufacturers and medical experts talked about the Chiron Corporation situation and suggested solutions to the shortage of vaccine manufacturing facilities.